Skip to main content

Table 2 Monomer composition of mcl-PHA produced by metabolically engineered P. putida strains in flask experiments

From: Production of medium chain length polyhydroxyalkanoate in metabolic flux optimized Pseudomonas putida

Strain

C6

C8

C10

C12

C12:1

C14

KT2440

n.d.

11.8 ± 0.2

73.0 ± 0.1

4.7 ± 0.2

9.4 ± 0.7

0.8 ± 0.3

KT2440Δ gcd

n.d.

14.0 ± 0.4

71.1 ± 0.8

4.6 ± 0.9

8.5 ± 0.4

1.1 ± 0.2

KT2440- acoA

n.d.

13.0 ± 0.6

69.1 ± 1.2

3.4 ± 0.7

10.5 ± 0.2

3.9 ± 0.2

KT2440Δ gcd-acoA

n.d.

14.8 ± 0.7

70.2 ± 1.4

5.1 ± 0.3

8.8 ± 0.1

0.7 ± 0.3

KT2440-pgl

n.d.

12.2 ± 0.9

74.1 ± 1.5

3.8 ± 0.5

9.9 ± 0.8

n.d.

KT2440Δ gcd-pgl

n.d.

14.6 ± 0.3

73.1 ± 0.8

3.7 ± 0.2

8.1 ± 0.5

0.5 ± 0.1

  1. n.d.: not detected, less than 0.2%.
  2. : The data were determined by GC/MS and are given as relative molar fraction (%) of C6: 3-hydroxyexanoate, C8: 3-hydroxyoctanoate, C10:3-hydroxydecanoate, C12: 3-hydroxydodecanoate, C12:1: 3-hydroxy-5-cis-dodecanoate, and C14: 3-hydroxytetradecanoate.